F16.980 Hallucinogen use, unspecified with hallucinogen-induced anxiety disorder
F16.980 is a risk-adjusting diagnosis under CMS-HCC models. Create a free account to see model versions, RAF contribution, and AI-powered HCC suppression analysis.
Get what a quick lookup can't: the AI assistant for official-guideline questions, HCC risk-adjustment mappings (CMS-HCC V24/V28, RxHCC), FDA drug indications, and AHA Coding Clinic references for F16.980.
The ICD-10-CM code for Hallucinogen use, unspecified with hallucinogen-induced anxiety disorder is F16.980 (FY2026). It is a billable, claim-ready diagnosis code.
Classification
- Section
- F10-F19: Mental and behavioral disorders due to psychoactive substance use (F10-F19)
- Category F16
- 53 codes (40 billable)
- FY2026 Status
- Stable since FY2024
Also Known As
ICD-10-CM Alphabetic Index entries that lead to F16.980:
- Phencyclidine-induced › anxiety disorder
- Disorder (of) › anxiety › due to (secondary to) › hallucinogen
- Use (of) › hallucinogen NEC › with › anxiety disorder
- Disorder (of) › anxiety › due to (secondary to) › phencyclidine
Inclusion Terms
- Other hallucinogen-induced anxiety disorder, without use disorder
- Phencyclidine induced anxiety disorder, without use disorder
U.S. Hospital Utilization
F16.980 appeared in too few sampled U.S. inpatient stays in 2023 to report a national estimate (AHRQ suppresses counts of 10 or fewer) — a rare inpatient diagnosis.
Source: National Inpatient Sample (NIS), Healthcare Cost and Utilization Project (HCUP), Agency for Healthcare Research and Quality, 2016–2023. National survey-weighted estimates.
Official Coding Guidelines
Unspecified psychoactive substance use (F10.9-–F19.9-)3) Psychoactive Substance Use, Unspecified As with all other unspecified diagnoses, the codes for unspecified psychoactive substance use (F10.9-, F11.9-, F12.9-, F13.9-, F14.9-, F15.9-, F16.9-, F18.9-, F19.9-) should only be assigned based on provider documentation and when they meet the definition of a reportable diagnosis (see Section III, Reporting Additional Diagnoses). These codes are to be used only when the psychoactive substance use is associated with a substance related disorder (chapter 5 disorders such as sexual dysfunction, sleep disorder, or a mental or behavioral disorder) or medical condition, and such a relationship is documented by the provider.
Pain disorders related to psychological factors (TOC entry)a. Pain disorders related to psychological factors ..................................................................... 43
Source: CMS — ICD-10-CM Official Guidelines for Coding and Reporting, FY2026
References
Cite This Page
Reference F16.980 with the canonical source and edition:
F16.980 — Hallucinogen use, unspecified with hallucinogen-induced anxiety disorder. ICD-10 Coding Pro (ICD-10-CM FY2026). https://icd10codingpro.com/codes/F16.980
Canonical URL: https://icd10codingpro.com/codes/F16.980